Q&AUpdated 6 min read
Selank withdrawal: dependence, benzodiazepines, and alcohol
Does selank cause withdrawal? What studies measured on dependence, how it compares with benzodiazepines, the rodent alcohol and opioid withdrawal studies, and the untested alcohol interaction.
By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed. Last verified
The short answer: nobody has studied selank withdrawal. The human research on selank consists of a few small, short Russian anxiety studies, and none of them measured dependence, tolerance or what happens when people stop. [3] The claim that selank causes no withdrawal, unlike benzodiazepines, is plausible but unproven. The claim that it treats withdrawal from benzodiazepines, alcohol or opioids rests on rat studies and one open add-on study. [6]
This Q&A covers what the studies measured. It is not a guide to stopping any medicine. If you take a benzodiazepine, do not stop or swap it without your prescriber.
Does selank cause withdrawal?
We found no study, human or animal, designed to test selank dependence or withdrawal.
What the clinical studies did report is limited:
- In 62 patients with generalized anxiety disorder or neurasthenia, selank relieved anxiety about as much as the benzodiazepine medazepam over a short course. The study compared effects during treatment, not after stopping. [3]
- In 60 patients with anxiety and somatoform disorders, the authors reported that selank's anti-anxiety effect lasted about a week after the last dose. [5]
A lingering effect after stopping is sometimes read as a sign of no rebound. That is an inference. Rebound anxiety and withdrawal need to be measured directly, with structured symptom scales after a planned stop, in people who used the drug for long enough to develop dependence. No selank study has done that. The courses studied were short, and the people using research-labeled selank today may use it far longer.
How does selank compare with benzodiazepines on dependence?
The comparison is the main reason people search for selank withdrawal, so it helps to be precise about what is known on each side.
Benzodiazepines. In 2020 FDA required a boxed warning on the whole benzodiazepine class covering abuse, misuse, addiction, physical dependence and withdrawal reactions. FDA warned that continued use can lead to clinically significant physical dependence and that abrupt stopping or rapid dose reduction can cause withdrawal reactions that can be life threatening. [14]
Selank. The developers and later researchers propose that selank acts partly through the GABA system, the same target as benzodiazepines. A rat study found that selank and GABA changed the expression of many of the same neurotransmission genes, and the authors suggested selank may act as an allosteric modulator of GABA signaling. [7] A second proposed mechanism is slowing the breakdown of the body's own enkephalins. [2] A 2018 review summarizes both lines of evidence. [10]
That overlap cuts both ways. It is why selank is compared with benzodiazepines, and it is also why a 2021 review of GABA-acting drugs grouped selank with phenibut as poorly studied Russian drugs sold to US consumers, warning that chronic use of GABA-acting drugs can lead to significant withdrawal syndromes and that new GABA-active agents should be evaluated for abuse potential before public access. [12] For selank that evaluation has not happened. The honest answer to "is selank addictive" is that it has not been tested.
Can selank help with benzodiazepine withdrawal?
It has not been tested as a withdrawal treatment. Two studies are sometimes cited:
- Human, randomized but open label. Seventy patients with anxiety disorders were randomly assigned to phenazepam alone or phenazepam plus selank, with no placebo group. The combination group reported fewer benzodiazepine side effects, such as sedation, memory problems and fatigue, both during treatment and after the tranquilizer was withdrawn. [6] The study was small, not blinded, and not designed to measure withdrawal severity.
- Rats. Under chronic stress, rats given selank and diazepam together showed the lowest anxiety measures, and the authors framed selank as changing how benzodiazepines act. [9]
Neither supports using selank to come off a benzodiazepine. FDA advises that benzodiazepines be tapered gradually under a clinician's supervision. [14] Adding an unapproved peptide with proposed GABA effects to that process adds unknowns, not safety.
Selank and alcohol: withdrawal studies and the interaction question
The alcohol research is all in rodents, from one Moscow laboratory:
- Alcohol withdrawal in rats. Rats that drank alcohol for 24 weeks were put through a 48-hour withdrawal. A single selank injection removed withdrawal-induced anxiety in behavioral tests and prevented increased pain sensitivity, without changing how much alcohol the rats drank. [4]
- Alcohol stimulation in mice. Selank blocked the expression of alcohol-induced motor sensitization in mice. [8]
- Alcohol and memory in rats. In rats given alcohol for 30 weeks, a week of selank prevented alcohol-related memory and attention problems and was linked to changes in BDNF in the hippocampus and frontal cortex. [11]
None of these studies tested what happens when a person drinks while using selank. Our selank entity record lists additive effects with alcohol and other GABA-acting drugs as a theoretical interaction because of the proposed GABA mechanism. [10] Alcohol, benzodiazepines and other sedatives can be dangerous together, and an untested GABA-active peptide should be treated with the same caution. People with alcohol use disorder have approved, evidence-based treatments; the anxiety condition page lists standard care for the anxiety that often drives these searches.
Selank and opioid withdrawal
One rat study tested this. In morphine-dependent rats, a single injection of selank reduced an overall withdrawal score by 39.6%, somewhat less than diazepam did at 49.3%. [13] Selank has not been tested in people withdrawing from opioids, and our entity record flags a theoretical interaction with opioids because of its effect on enkephalin-degrading enzymes. Opioid withdrawal has approved medical treatments, and a rat study is no reason to use an unapproved peptide instead.
Is selank legal in the US?
Selank has no federal compounding basis. FDA placed it on its 503A Category 2 list in 2023 and now lists it as a withdrawn nomination, which takes it off Category 2 without putting it on the bulks list. [15] It was not among the peptides FDA presented to the Pharmacy Compounding Advisory Committee on July 23 to 24, 2026. [16] It is also not one of the six peptides in HHS's October 2026 draft enforcement discretion policy. [1] Our explainer on the draft HHS policy covers its conditions and what did not change. The selank regulatory tracker records each step, and the legal hub covers state rules. The selank cost page explains why there is no lawful price.
Our guide to getting peptides prescribed lists the peptides that do have a lawful route, and what is peptide therapy explains how clinics use the term.
Where selank fits
If you are weighing selank against related compounds, see semax vs selank and selank vs noopept. For the route question and why no trial has tested semax and selank together, see our selank nasal spray explainer.
The bottom line
No study has measured selank dependence or withdrawal, in people or animals. Its proposed GABA mechanism is the reason it is compared with benzodiazepines, and the same reason its abuse and withdrawal potential should have been studied before it was sold. The withdrawal-treatment claims come from rodents and one small open study. If you are trying to stop a benzodiazepine, alcohol or opioids, a clinician can offer tapering plans and approved treatments with real evidence behind them.
What's actually offered, and what that means for you
FDA has found a compounding pharmacy offering selank anyway. [17]
What that means for you
- A pharmacy that compounds selank is taking a regulatory risk: it has no federal basis to do so, and FDA has sent warning letters to compounders for the same thing. [18] [19]
- No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [20]
- State boards can act. On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [21]
- Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [22] [23]
If you're going ahead anyway
Each step is on the selank page: check the pharmacy's license, what a legitimate prescription and consult look like, why this is safer than a research-use-only product, and questions to ask. These steps lower some risks. They do not make the product safe, and they do not give a pharmacy a federal basis to compound selank, with or without a prescription. [24]
Decisions about starting, stopping, or combining any treatment belong with a licensed clinician who knows your history.
Pages referenced in this article
- PeptideSelank
- ConditionAnxiety disorders
- ComparisonSemax vs Selank
- ComparisonSelank vs Noopept
- RegulatorySelank regulatory timeline
- CostSelank cost
- IndexState legal guides
Frequently asked questions
Does selank cause withdrawal symptoms?
No study has measured it. The small Russian clinical studies were short courses and did not look for dependence or withdrawal. One reported that the anti-anxiety effect lasted about a week after the last dose, which is not the same as testing what happens when people stop. [3] [5]
Is selank addictive like benzodiazepines?
Unknown. Benzodiazepines carry an FDA boxed warning for abuse, addiction, physical dependence and withdrawal reactions. Selank has proposed GABA-related effects, and a 2021 pharmacology review said GABA-acting drugs should be evaluated for abuse potential before public access. That evaluation has not been done for selank. [7] [12] [14]
Can selank help with benzodiazepine withdrawal?
It has not been tested for that. In one open Russian study, adding selank to phenazepam reduced some benzodiazepine side effects during treatment and after the tranquilizer was stopped, but that was not a withdrawal trial. Never stop a benzodiazepine abruptly; FDA advises a gradual taper with a clinician. [6] [14]
Can you drink alcohol with selank?
The interaction has never been studied in people. Rodent studies found selank reduced anxiety during alcohol withdrawal and blunted some effects of alcohol, but those were animal experiments. Because selank is thought to act partly on GABA signaling, the same system alcohol affects, additive sedation is a plausible untested risk. [4] [8] [10]
Sources
Numbered citations in the article point to these primary sources. PubMed entries link to the indexed abstract. Evidence grades follow our methodology.
- [1]HHS: Enforcement discretion policy regarding 503A compounding using certain peptide bulk drug substances, with Appendix A and Appendix B (draft, October 2026)2026
- [2]Zozulya AA et al. The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity. Bull Exp Biol Med 2001PubMed 11550013, 2001
- [3]Zozulya AA et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zh Nevrol Psikhiatr Im S S Korsakova 2008PubMed 18454096, 2008
- [4]Kolik LG et al. Efficacy of peptide anxiolytic selank during modeling of withdrawal syndrome in rats with stable alcoholic motivation. Bull Exp Biol Med 2014PubMed 24913576, 2014
- [5]Medvedev VE et al. A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders. Zh Nevrol Psikhiatr Im S S Korsakova 2014PubMed 25176261, 2014
- [6]Medvedev VE et al. Optimization of the treatment of anxiety disorders with selank. Zh Nevrol Psikhiatr Im S S Korsakova 2015PubMed 26356395, 2015
- [7]Volkova A et al. Selank administration affects the expression of some genes involved in GABAergic neurotransmission. Front Pharmacol 2016PubMed 26924987, 2016
- [8]Kolik LG et al. Selank inhibits ethanol-induced hyperlocomotion and manifestation of behavioral sensitization in DBA/2 mice. Bull Exp Biol Med 2016PubMed 27878720, 2016
- [9]Kasian A et al. Peptide Selank enhances the effect of diazepam in reducing anxiety in unpredictable chronic mild stress conditions in rats. Behav Neurol 2017PubMed 28280289, 2017
- [10]Vyunova TV et al. Peptide-based anxiolytics: the molecular aspects of heptapeptide selank biological activity. Protein Pept Lett 2018PubMed 30255741, 2018